GLP-1 agonists have proven highly effective in managing type 2 diabetes and related metabolic disorders, offering benefits such as improved glycemic control, weight loss, enhanced cardiovascular and renal health, and potential neuroprotective effects. The gene discussed is GCG; the disease is type 2 diabetes mellitus.